NPC Submits Comments to FDA on Exchange of Clinical and Economic Information
In comments submitted to the FDA, NPC outlined ways to improve how the exchange of clinical and economic information between biopharmaceutical manufacturers, payers, and population-health decision makers is regulated.
Health Plan Use of Patient Data: From the Routine to the Transformational
Health plans collect huge amounts of data through electronic health records, administrative claims, mobile health devices and other sources. This white paper explores whether the data simply sits on a shelf, or is used to shape care delivery, improve system efficiency, and achieve better health outcomes.
National Eczema Association Weighs In on Value Assessment Frameworks
NPC President Dan Leonard recently sat down for a conversation with Julie Block, President and CEO of the National Eczema Association, to discuss atopic dermatitis (AD) and value assessment frameworks.